Zobrazeno 1 - 10
of 55 833
pro vyhledávání: ''
Autor:
Ulrich Gatzemeier, Michael Boyer, Paolo Paoletti, Salih Emri, Christian Manegold, Claude Denham, Nicholas J. Vogelzang, James J. Rusthoven, James T. Symanowski, Clet Niyikiza, E. Kaukel, Pierre Ruffié
Publikováno v:
Journal of Clinical Oncology. 41:2125-2133
PURPOSE Patients with malignant pleural mesothelioma, a rapidly progressing malignancy with a median survival time of 6 to 9 months, have previously responded poorly to chemotherapy. We conducted a phase III trial to determine whether treatment with
Autor:
Lajos Pusztai, Gabriel N. Hortobagyi, Bryan T. Hennessy, Massimo Cristofanilli, Chafika Mazouni, Fabrice Andre, Attila Tordai, W. Fraser Symmans, Cornelia Liedtke, Marjorie C. Green, Ana M. Gonzalez-Angulo, Kenneth R. Hess, Jaime A. Mejia
Publikováno v:
Journal of Clinical Oncology. 41:1809-1815
PURPOSE Triple-negative breast cancer (TNBC) is defined by the lack of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER-2) expression. In this study, we compared response to neoadjuvant chemotherap
Publikováno v:
Journal of Clinical Oncology. 41:1331-1338
PURPOSE Immunohistochemistry (IHC) is a newer technique for assessing the estrogen receptor (ER) status of breast cancers, with the potential to overcome many of the shortcomings associated with the traditional ligand-binding assay (LBA). The purpose
Autor:
Tatiana Pinheiro, Inês Ramião, Nuno BorgesRD, Conceição Calhau, Fernando Macário, J. Pereira, Teresa Adragão, Rita Figueiredo, Pedro Lourenço, Brígida Velez, Vitor Sá Martins, Leila Aguiar, Tânia Pascoal, Catarina Dias, Iola Pinto, Ana Luisa Papoila Al
Publikováno v:
Journal of Renal Nutrition. 32:569-577
Objective: Since its development, cumulative evidence has accumulated regarding the prognostic value of the Malnutrition-Inflammation Score (MIS/Kalantar score) prognostic value; however, there is a shortage of recent and large studies with comprehen
Autor:
Achim Lusch, Carolin Buddensieck, Yue Che, P. Albers, Andreas Hiester, C. Winter, Robert Große Siemer
Publikováno v:
Journal of Urology. 207:617-626
Purpose The oncological benefit of postchemotherapy residual tumor resection (PC-RTR) in patients with germ cell tumors and elevated serum tumor markers (STMs) remains unclear. This analysis was performed to better define patients who benefit from su
Autor:
Michael Glikson, Nir Levi, Amir Orlev, Adi Butnaru, Daniel Belman, Ziv Dadon, Evan Avraham Alpert, Shmuel Gottlieb
Publikováno v:
The Canadian Journal of Cardiology
Background Strict isolation precautions limit formal echocardiogram use in the setting of COVID-19 infection. Information on the importance of the utilization of a hand-held focused ultrasound for cardiac evaluation in these patients is scarce. This
Publikováno v:
European Journal of Surgical Oncology. 48:666-671
Background Oophorectomy is a common procedure in women with peritoneal metastasis (PM) undergoing cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC), which has unique consequences on hormonal balance and fertility befor
Autor:
Eduardo Garcia Vilela, Henrique Rocha
Publikováno v:
Gastroenterología y Hepatología. 45:83-90
Background and aims Inflammatory bowel diseases (IBD) are chronic conditions that may be accompanied by autoimmune liver disease (AILD), most commonly primary sclerosing cholangitis (PSC). The objective of this study was to evaluate the behaviour of
Autor:
Alexandre Ingels, Frédéric Pigneur, Florence Canoui-Poitrine, Yaniss Ouamri, Vincent Audard, Thomas Stehlé, Antoine Morel, Marie Matignon, Sébastien Mulé, Alain Luciani, Cécile Maud Champy, Philippe Grimbert
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 13, Iss 1, Pp 386-396 (2022)
Background Patients with end‐stage renal disease may display both a loss of skeletal muscle mass and an increase in muscle fat deposits. We aimed to analyse the impact of low skeletal muscle mass index (SMI, surrogate marker of sarcopenia) and low
Autor:
Andreia Campinas, André Luz, Marta Fontes Oliveira, Mário Santos, Ricardo A. Costa, André Frias, Severo Torres, Maria Trêpa
Publikováno v:
The American Journal of Cardiology. 164:14-20
ST-elevation myocardial infarction (STEMI) survivors have a heightened risk of developing heart failure (HF). The magnitude of this risk with the advent of primary percutaneous coronary intervention is less characterized. We aimed to examine the inci